Background/Aims: Acute kidney injury (AKI) in critically ill patients is common, and continuous renal replacement therapy (CRRT) is a preferred mode of renal replacement therapy (RRT) in hemodynamically unstable patients. Prediction of clinical outcomes in patients on CRRT is challenging. We utilized several approaches to predict RRT-free survival (RRTFS) in critically ill patients with AKI requiring CRRT. Methods: We used the Medical Information Mart for Intensive Care (MIMIC-III) database to identify patients ≥18 years old with AKI on CRRT, after excluding patients who had ESRD on chronic dialysis, and kidney transplantation. We defined RRTFS as patients who were discharged alive and did not require RRT ≥7 days prior to hospital discharge. We utilized all available biomedical data up to CRRT initiation. We evaluated 7 approaches, including logistic regression (LR), random forest (RF), support vector machine (SVM), adaptive boosting (AdaBoost), extreme gradient boosting (XGBoost), multilayer perceptron (MLP), and MLP with long short-term memory (MLP + LSTM). We evaluated model performance by using area under the receiver operating characteristic (AUROC) curves. Results: Out of 684 patients with AKI on CRRT, 205 (30%) patients had RRTFS. The median age of patients was 63 years and their median Simplified Acute Physiology Score (SAPS) II was 67 (interquartile range 52–84). The MLP + LSTM showed the highest AUROC (95% CI) of 0.70 (0.67–0.73), followed by MLP 0.59 (0.54–0.64), LR 0.57 (0.52–0.62), SVM 0.51 (0.46–0.56), AdaBoost 0.51 (0.46–0.55), RF 0.44 (0.39–0.48), and XGBoost 0.43 (CI 0.38–0.47). Conclusions: A MLP + LSTM model outperformed other approaches for predicting RRTFS. Performance could be further improved by incorporating other data types.

1.
Hoste
EA
,
Clermont
G
,
Kersten
A
,
Venkataraman
R
,
Angus
DC
,
De Bacquer
D
, et al.
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis
.
Crit Care
.
2006
;
10
(
3
):
R73
.
2.
Kidney Disease Improving Global Outcome (KDIGO) Acute Kidney Injury Working Group
.
KDIGO clinical practice guideline for acute kidney injury
.
Kidney Int Suppl
.
2012
;
2
:
1
138
.
3.
Garay
OU
,
Palacios
A
,
Pichon-Riviere
A
,
Augustovski
F
,
Martí
SG
,
Hernández-Vásquez
A
, et al.
The cost-effectiveness of continuous versus intermittent renal replacement therapies in acute kidney injury: perspective of the social services for the elderly in Argentina
.
Value Health Reg Issues
.
2019 Dec
;
20
:
142
8
.
4.
Prasad
B
,
Urbanski
M
,
Ferguson
TW
,
Karreman
E
,
Tangri
N
.
Early mortality on continuous renal replacement therapy (CRRT): the prairie CRRT study
.
Can J Kidney Health Dis
.
2016
;
3
:
36
.
5.
Schneider
AG
,
Bellomo
R
,
Bagshaw
SM
,
Glassford
NJ
,
Lo
S
,
Jun
M
, et al.
Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis
.
Intensive Care Med
.
2013 Jun
;
39
(
6
):
987
97
.
6.
de Souza Oliveira
MA
,
Dos Santos
TOC
,
Monte
JCM
,
Batista
MC
,
Pereira
VG
,
Dos Santos
BFC
, et al.
The impact of continuous renal replacement therapy on renal outcomes in dialysis-requiring acute kidney injury may be related to the baseline kidney function
.
BMC Nephrol
.
2017 May
;
18
(
1
):
150
.
7.
da Hora Passos
R
,
Ramos
JG
,
Mendonça
EJ
,
Miranda
EA
,
Dutra
FR
,
Coelho
MF
, et al.
A clinical score to predict mortality in septic acute kidney injury patients requiring continuous renal replacement therapy: the HELENICC score
.
BMC Anesthesiol
.
2017 Feb
;
17
(
1
):
21
.
8.
Kim
Y
,
Park
N
,
Kim
J
,
Kim
DK
,
Chin
HJ
,
Na
KY
, et al.
Development of a new mortality scoring system for acute kidney injury with continuous renal replacement therapy
.
Nephrology
.
2019 Dec
;
24
(
12
):
1233
40
.
9.
Fayad
AI
,
Buamscha
DG
,
Ciapponi
A
.
Intensity of continuous renal replacement therapy for acute kidney injury
.
Cochrane Database Syst Rev
.
2016 Oct
;
10
:
CD010613
.
10.
Gaudry
S
,
Hajage
D
,
Schortgen
F
,
Martin-Lefevre
L
,
Pons
B
,
Boulet
E
, et al.
Initiation strategies for renal-replacement therapy in the intensive care unit
.
N Engl J Med
.
2016 Jul
;
375
(
2
):
122
33
.
11.
Zarbock
A
,
Kellum
JA
,
Schmidt
C
,
Van Aken
H
,
Wempe
C
,
Pavenstädt
H
, et al.
Effect of early vs delayed initiation of renal replacement therapy on mortality in critically Ill patients with acute kidney injury: the ELAIN randomized clinical trial
.
JAMA
.
2016 May
;
315
(
20
):
2190
9
.
12.
Chen
X
,
Chen
Z
,
Wei
T
,
Li
P
,
Zhang
L
,
Fu
P
.
The effect of serum neutrophil gelatinase-associated lipocalin on the discontinuation of continuous renal replacement therapy in critically Ill patients with acute kidney injury
.
Blood Purif
.
2019 Mar
;
48
(
1
):
10
7
.
13.
Katayama
S
,
Uchino
S
,
Uji
M
,
Ohnuma
T
,
Namba
Y
,
Kawarazaki
H
, et al.
Factors predicting successful discontinuation of continuous renal replacement therapy
.
Anaesth Intensive Care
.
2016 Jul
;
44
(
4
):
453
7
.
14.
Woodward
CW
,
Lambert
J
,
Ortiz-Soriano
V
,
Li
Y
,
Ruiz-Conejo
M
,
Bissell
BD
, et al.
Fluid overload associates with major adverse kidney events in critically Ill patients with acute kidney injury requiring continuous renal replacement therapy
.
Crit Care Med
.
2019
;
47
(
9
):
e753
60
.
15.
Murugan
R
,
Kerti
SJ
,
Chang
CH
,
Gallagher
M
,
Clermont
G
,
Palevsky
PM
, et al.
Association of net ultrafiltration rate with mortality among critically Ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial
.
JAMA Netw Open
.
2019 Jun 5
;
2
(
6
):
e195418
.
16.
Bzdok
D
,
Altman
N
,
Krzywinski
M
.
Statistics versus machine learning
.
Nat Methods
.
2018
;
15
(
4
):
233
4
.
17.
Nadkarni
GN
,
Chaudhary
K
,
Coca
SG
.
Machine learning in glomerular diseases: promise for precision medicine
.
Am J Kidney Dis
.
2019 Sep
;
74
(
3
):
290
2
.
18.
Saez-Rodriguez
J
,
Rinschen
MM
,
Floege
J
,
Kramann
R
.
Big science and big data in nephrology
.
Kidney Int
.
2019 Jun
;
95
(
6
):
1326
37
.
19.
Johnson
AE
,
Pollard
TJ
,
Shen
L
,
Lehman
LW
,
Feng
M
,
Ghassemi
M
, et al.
MIMIC-III, a freely accessible critical care database
.
Sci Data
.
2016 May
;
3
:
160035
.
20.
Collins
GS
,
Reitsma
JB
,
Altman
DG
,
Moons
KGM
.
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
.
BMJ
.
2015 Jan
;
350
:
g7594
.
21.
Breiman
L
.
Random forests
.
Mach Learn
.
2001 Oct
;
45
(
1
):
5
32
.
22.
Shouval
R
,
Bondi
O
,
Mishan
H
,
Shimoni
A
,
Unger
R
,
Nagler
A
.
Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT
.
Bone Marrow Transplant
.
2014 Mar
;
49
(
3
):
332
7
.
23.
Friedman
J
,
Hastie
T
,
Tibshirani
R
.
Additive logistic regression: a statistical view of boosting
.
Ann Stat
.
2000
;
28
(
2
):
337
407
.
24.
Chen
T
,
Guestrin
C
.
XGBoost: a scalable tree boosting system
.
CoRR
.
2016
:
785
94
.
abs/1603.02754. Available from: http://arxiv.org/abs/1603.02754
25.
Min
S
,
Lee
B
,
Yoon
S
.
Deep learning in bioinformatics
.
Brief Bioinformatics
.
2017 Sep 1
;
18
(
5
):
851
69
.
26.
Singh
A
,
Nadkarni
G
,
Gottesman
O
,
Ellis
SB
,
Bottinger
EP
,
Guttag
JV
.
Incorporating temporal EHR data in predictive models for risk stratification of renal function deterioration
.
J Biomed Inform
.
2015 Feb
;
53
:
220
8
.
27.
Le Gall
JR
,
Lemeshow
S
,
Saulnier
F
.
A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study
.
JAMA
.
1993 Dec
;
270
(
24
):
2957
63
.
28.
Palevsky
PM
,
Palevsky
PM
,
Zhang
JH
,
O’Connor
TZ
,
Chertow
GM
,
Crowley
ST
, et al.
Intensity of renal support in critically ill patients with acute kidney injury
.
N Engl J Med
.
2008 Jul
;
359
(
1
):
7
20
.
29.
Kang
MW
,
Kim
J
,
Kim
DK
,
Oh
KH
,
Joo
KW
,
Kim
YS
, et al.
Machine learning algorithm to predict mortality in patients undergoing continuous renal replacement therapy
.
Crit Care
.
2020 Feb
;
24
(
1
):
42
.
30.
Breiman
L
.
Statistical modeling: the two cultures (with comments and a rejoinder by the author)
.
Statist Sci
.
2001 Aug
;
16
(
3
):
199
231
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.